323958155	323958155	CD	B-NP	O
|	|	NN	I-NP	O
LPDH	LPDH	NN	I-NP	O
|	|	NN	I-NP	O
09908285	09908285	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9481940	9481940	CD	B-NP	O
|	|	CC	I-NP	O
5/28/2003	5/28/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/2003	10/28/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/3/2003	2/3/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
BECKET	BECKET	NNP	B-NP	O
,	,	,	O	O
BRANDON	BRANDON	NNP	B-NP	O
992-69-13-7	992-69-13-7	CD	I-NP	O
Histon	Histon	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
PUL	PUL	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
3/17/03	3/17/03	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HEMPHILL	HEMPHILL	NNP	B-NP	O
,	,	,	O	O
ROBT	ROBT	NNP	B-NP	O
MYRON	MYRON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
650	650	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
headache	headache	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CHILDREN	CHILDREN	NNP	I-NP	O
'S	'S	POS	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q2H	Q2H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Shortness	Shortness	NN	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
MIACALCIN	MIACALCIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCITONIN-SALMON	CALCITONIN-SALMON	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
CEFTAZIDIME	CEFTAZIDIME	NN	I-NP	O
2	2	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
MG	MG	NN	I-NP	O
IV	IV	CD	B-NP	O
Q8H	Q8H	NN	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/19/03	4/19/03	CD	B-NP	O
by	by	IN	B-PP	O
RICKE	RICKE	NNP	B-NP	O
,	,	,	O	O
GREGORY	GREGORY	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
CEPHALOSPORINS	CEPHALOSPORINS	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
observe	observe	VB	I-VP	O
carefully	carefully	RB	B-NP	O
FLEXERIL	FLEXERIL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CYCLOBENZAPRINE	CYCLOBENZAPRINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HEPARIN	HEPARIN	NNP	I-NP	O
5	5	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
U	U	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
SC	SC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
BID	BID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
may	may	MD	B-VP	O
use	use	VB	I-VP	O
am	am	NN	B-NP	O
lab	lab	NN	I-NP	O
draw	draw	NN	I-NP	O
results	result	NNS	I-NP	O
for	for	IN	B-PP	O
am	am	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
fingerstick	fingerstick	NN	B-NP	O
in	in	IN	B-PP	O
pm	pm	NN	B-NP	O
.	.	.	O	O

thank	thank	VB	B-VP	O
you	you	PRP	B-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
200	200	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
ATIVAN	ATIVAN	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6-8H	Q6-8H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Anxiety	Anxiety	NN	I-NP	O
MAALOX	MAALOX	NN	I-NP	O
PLUS	PLUS	NN	I-NP	O
EXTRA	EXTRA	NN	I-NP	O
STRENGTH	STRENGTH	NN	I-NP	O
15	15	CD	B-NP	O
milliliters	milliliter	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Indigestion	Indigestion	NN	I-NP	O
MOM	MOM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MAGNESIUM	MAGNESIUM	NN	I-NP	O
HYDROXIDE	HYDROXIDE	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
30	30	CD	B-NP	O
milliliters	milliliter	NNS	I-NP	O
PO	PO	NNP	B-NP	O
QD	QD	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
TOBRAMYCIN	TOBRAMYCIN	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
140	140	CD	I-NP	O
MG	MG	NN	I-NP	O
IV	IV	CD	B-NP	O
Q8H	Q8H	NN	I-NP	B-DNA
MS	MS	NN	I-NP	I-DNA
CONTIN	CONTIN	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
MORPHINE	MORPHINE	NNP	I-NP	I-DNA
SUSTAINED	SUSTAINED	NNP	I-NP	I-DNA
RELEASE	RELEASE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
15	15	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
Q12H	Q12H	NNP	I-NP	I-DNA
PRN	PRN	NNP	I-NP	I-DNA
Pain	Pain	NNP	I-NP	I-DNA
PRAVACHOL	PRAVACHOL	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
PRAVASTATIN	PRAVASTATIN	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
80	80	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

HUMIBID	HUMIBID	NNP	B-NP	O
L.A.	L.A.	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GUAIFENESIN	GUAIFENESIN	NNP	I-NP	O
CR	CR	NNP	I-NP	O
TABLET	TABLET	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
LISINOPRIL/HYDROCLOROTHIAZIDE	LISINOPRIL/HYDROCLOROTHIAZIDE	NN	I-NP	O
20/25	20/25	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
BACTRIM	BACTRIM	NN	I-NP	O
DS	DS	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
TRIMETHOPRIM	TRIMETHOPRIM	NN	I-NP	O
/	/	SYM	I-NP	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NN	I-NP	O
DO	DO	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
M	M	NNP	I-NP	O
,	,	,	O	O
W	W	NNP	B-NP	O
,	,	,	O	O
F	F	NNP	B-NP	O
TIAZAC	TIAZAC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ALLEGRA	ALLEGRA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
FEXOFENADINE	FEXOFENADINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
180	180	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

PULMICORT	PULMICORT	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BUDESONIDE	BUDESONIDE	NNP	I-NP	O
ORAL	ORAL	NNP	I-NP	O
INHALER	INHALER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
NEB	NEB	NN	I-NP	O
BID	BID	NN	I-NP	O
PROVENTIL	PROVENTIL	NN	I-NP	O
HFA	HFA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
HFA	HFA	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
SINGULAIR	SINGULAIR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MONTELUKAST	MONTELUKAST	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	B-DNA
ADVAIR	ADVAIR	NNP	I-NP	I-DNA
DISKUS	DISKUS	NNP	I-NP	I-DNA
250/50	250/50	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
BID	BID	NN	I-NP	O
CALTRATE	CALTRATE	NN	I-NP	O
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	B-protein
CARB	CARB	NN	I-NP	I-protein
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
600MG	600MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
CA	CA	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DUONEB	DUONEB	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
AND	AND	CC	O	O
IPRATROPIUM	IPRATROPIUM	NNP	B-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PREDNISONE	PREDNISONE	NNP	I-NP	O
Taper	Taper	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Give	Give	NNP	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
8/11/03	8/11/03	CD	B-NP	O
-08	-08	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
--	--	:	O	O
done	do	VBN	B-VP	O
Give	Give	IN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
11/15/03	11/15/03	CD	B-NP	O
-08	-08	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
--	--	:	O	O
done	do	VBN	B-ADJP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
10	10	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
3/9/03	3/9/03	CD	B-NP	O
-08	-08	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
--	--	:	O	O
done	do	VBN	B-VP	O
After	After	IN	B-PP	O
taper	taper	NN	B-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
PREDNISONE	PREDNISONE	NN	B-NP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Osuch	Osuch	NNP	I-NP	O
-	-	HYPH	O	O
9	9	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
11/19/03	11/19/03	CD	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Shellfish	Shellfish	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
pneumonia	pneumonia	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gerd	gerd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
copd	copd	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
66	66	CD	B-NP	O
y/o	y/o	NN	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
severe	severe	JJ	I-NP	O
asthma/COPD	asthma/COPD	NN	I-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
never	never	RB	B-VP	O
intubated	intubate	VBN	I-VP	O
,	,	,	O	O
now	now	RB	B-ADJP	O
w	w	JJ	I-ADJP	O
/	/	SYM	B-NP	O
recurrent	recurrent	JJ	I-NP	O
pseudomonas	pseudomonas	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Sensitive	Sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
and	and	CC	I-NP	O
tobramycin	tobramycin	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
general	general	JJ	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
NAD	NAD	NN	I-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
Cushingoid	Cushingoid	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
:	:	:	O	O
faint	faint	JJ	B-NP	O
BS	BS	NNP	I-NP	O
,	,	,	O	O
scattered	scatter	VBD	B-VP	O
wheezes	wheeze	VBZ	B-VP	O
CVS	CVS	NN	B-NP	O
:	:	:	O	O
faint	faint	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	O
Abdomen	Abdoman	NNS	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
protuberant	protuberant	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
bs	b	NNS	I-NP	O
Plan	Plan	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

pulmonary	pulmonary	JJ	B-ADJP	O
:	:	:	O	O
O2	O2	NN	B-NP	O
by	by	IN	B-PP	O
NC	NC	NN	B-NP	B-protein
sats	sat	NNS	I-NP	I-protein
>	>	SYM	O	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Tapered	Taper	VBN	B-VP	O
Pred	Pre	VBN	B-VP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
7/21/03	7/21/03	CD	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
txfr	txfr	NN	B-NP	O
with	with	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
ceftz/tobramycin	ceftz/tobramycin	NN	B-NP	O
-	-	HYPH	B-NP	O
iv	iv	NN	I-NP	O
.	.	.	O	O

Picc	Picc	NNP	B-NP	O
placed	place	VBD	B-VP	O
10/21/03	10/21/03	CD	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
cardizem	cardizem	NN	B-NP	O
,	,	,	O	O
pravachol	pravachol	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
ECHO	ECHO	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	B-protein
55	55	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
4	4	CD	B-NP	I-protein
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
prevacid	prevacid	NN	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
fs	f	NNS	B-NP	O
qpm	qpm	NN	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Musculoskel	Musculoskel	NN	B-NP	O
:	:	:	O	O
Persistent	Persistent	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
attributed	attribute	VBN	B-VP	O
to	to	TO	B-PP	O
coughing	coughing	NN	B-NP	O
.	.	.	O	O

rec	rec	NN	B-NP	O
'd	'd	MD	B-VP	O
lidocaine	lidocaine	NN	B-NP	O
injxn	injxn	NN	I-NP	O
to	to	TO	B-VP	O
shoulder	shoulder	VB	I-VP	O
Sat	Sat	NNP	B-NP	B-protein
7/6	7/6	CD	I-NP	I-protein
for	for	IN	B-PP	O
musculoskel	musculoskel	NN	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

also	also	RB	B-ADVP	O
MSo4	MSo4	NN	B-NP	O
and	and	CC	I-NP	O
flexeril	flexeril	NN	I-NP	O
.	.	.	O	O

Would	Would	MD	B-VP	O
like	like	VB	I-VP	O
to	to	TO	I-VP	O
wean	wean	VB	I-VP	O
pt	pt	NN	B-NP	O
off	off	IN	B-PP	O
morphine	morphine	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Anxiety	Anxiety	NN	B-NP	O
:	:	:	O	O
ativan	ativan	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q8	q8	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
continue	continue	VBP	B-VP	O
IV	IV	CD	B-NP	O
tobramycin	tobramycin	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
switch	switch	NN	B-NP	O
to	to	TO	B-PP	O
Toby	Toby	NNP	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
patient	patient	NN	B-NP	O
worsens	worsen	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
return	return	NN	B-NP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
tobramycin	tobramycin	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
IV	IV	CD	B-NP	O
ceftaz	ceftaz	NN	I-NP	O
x	x	SYM	B-NP	O
14d	14d	NN	I-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
:	:	:	O	O
30mg	30mg	CD	B-NP	O
qd	qd	NN	I-NP	O
x	x	SYM	B-NP	O
3d	3d	CD	B-NP	O
;	;	:	O	O
25mg	25mg	CD	B-NP	O
qd	qd	NN	I-NP	O
x	x	SYM	B-NP	O
3d	3d	NN	I-NP	O
;	;	:	O	O
20mg	20mg	CD	B-NP	O
qd	qd	NN	I-NP	O
indefinitely	indefinitely	RB	B-ADVP	O
Can	Can	MD	B-VP	O
page	page	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Bolinsky	Bolinsky	NNP	I-NP	O
at	at	IN	B-PP	O
TTH	TTH	NNP	B-NP	O
pager	pager	NN	I-NP	O
#	#	#	B-NP	O
72118	72118	CD	I-NP	O
Pain	Pain	NNP	I-NP	O
management	management	NN	I-NP	O
:	:	:	O	O
offer	offer	NN	B-NP	O
tylenol	tylenol	NN	I-NP	O
first	first	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
F/u	F/u	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jahn	Jahn	NNP	I-NP	O
No	No	NNP	I-NP	O
dictated	dictate	VBD	B-VP	O
summary	summary	JJ	B-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
LOKHMATOR	LOKHMATOR	NNP	B-NP	O
,	,	,	O	O
ARRON	ARRON	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SM58	SM58	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/17/03	3/17/03	CD	I-NP	O
@	@	SYM	B-NP	O
09	09	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

